Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.47
+0.01000.22%
Post-market: 4.30-0.1700-3.80%19:23 EDT
Volume:18.75K
Turnover:82.61K
Market Cap:16.58M
PE:-0.34
High:4.57
Open:4.41
Low:4.18
Close:4.46
Loading ...

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

MT Newswires Live
·
15 Oct 2024

BriaCell gains after update on late-stage trial for lead asset

seekingalpha
·
15 Oct 2024

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire
·
15 Oct 2024

BriaCell Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Oct 2024

BriaCell’s Bria-IMT Regimen Shows Promise for Metastatic Breast Cancer with Brain Metastasis: A Buy Recommendation

TIPRANKS
·
03 Oct 2024

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

MT Newswires Live
·
03 Oct 2024

BRIEF-Briacell Therapeutics Announces Closing Of $5 Million Offering

Reuters
·
03 Oct 2024

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire
·
03 Oct 2024

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires Live
·
02 Oct 2024

BriaCell Therapeutics Launches $5 Million Offering

TIPRANKS
·
02 Oct 2024

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire
·
02 Oct 2024

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

MT Newswires Live
·
01 Oct 2024

BriaCell reports anti-tumor response in patient treated in Phase 2 study

TIPRANKS
·
01 Oct 2024

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire
·
01 Oct 2024

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks
·
28 Sep 2024